ABSTRACT
Salivary gland neoplasms make up around 6% of all head and neck tumors. The incidence of these neoplasms as a whole is approximately 5.5 cases per 100,000 persons in the United States, whereas malignant salivary gland neoplasms account for 0.9 cases per 100,000 individuals. Although the mortality rate from these malignant salivary gland neoplasms is very less, it varies by pathology and stages. The overall five-year survival rate of the neoplasm is 72%. Tumors that originate within the salivary glands are comparatively rare, but they often represent a wide variety of both malignant and benign neoplasms with various histologic subtypes. Although there are numerous literature written for this varied type of tumors over the decade, the accurate diagnosis and management of these salivary gland neoplasms remain complex and pose a great challenge for a head and neck surgeon.
